| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells. | J Exp Med | 2003 | 11.08 |
| 2 | CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells. | J Immunol | 2005 | 6.95 |
| 3 | IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells. | Proc Natl Acad Sci U S A | 2004 | 4.70 |
| 4 | Poor immunogenicity of a self/tumor antigen derives from peptide-MHC-I instability and is independent of tolerance. | J Clin Invest | 2004 | 1.30 |
| 5 | Deletion of Mthfd1l causes embryonic lethality and neural tube and craniofacial defects in mice. | Proc Natl Acad Sci U S A | 2012 | 1.16 |
| 6 | CTLA-4 dysregulation of self/tumor-reactive CD8+ T-cell function is CD4+ T-cell dependent. | Blood | 2006 | 1.14 |
| 7 | Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancer. | J Leukoc Biol | 2004 | 1.12 |